（CHBe-）患者血终止使用ETV或TDF（HBcrAg）的动力学研究

StephenW

The Liver Meeting San Francisco November 2018 Back

KINETICS OF SERUM HEPATITIS B CORE RELATED ANTIGEN (HBcrAg) IN NON-CIRRHOTIC HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHBe-) PATIENTS WHO DISCONTINUE EFFECTIVE LONG-TERM THERAPY WITH ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF)           Reported by Jules Levin AASLD Nov 9-13 SF M Papatheodoridi1, F Berby, B Testoni2, E Hadziyannis3, K Zachou4, A Lyberopoulou4, GN Dalekos4, F Zoulim2, GV Papatheodoridis1. 1Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece; 2Department of Hepatology, Hospices Civils de Lyon, CRCL-INSERM U1052, Lyon University, Lyon, France; 32nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, Hippokratio General Hospital, Athens, Greece. 4Department of Medicine and Research Laboratory of Internal Medicine, Thessaly University Medical School, Larissa, Greece.